Checkpoint kinase 1 is essential for fetal and adult hematopoiesis.

EMBO Reports
Fabian SchulerAndreas Villunger

Abstract

Checkpoint kinase 1 (CHK1) is critical for S-phase fidelity and preventing premature mitotic entry in the presence of DNA damage. Tumor cells have developed a strong dependence on CHK1 for survival, and hence, this kinase has developed into a promising drug target. Chk1 deficiency in mice results in blastocyst death due to G2/M checkpoint failure showing that it is an essential gene and may be difficult to target therapeutically. Here, we show that chemical inhibition of CHK1 kills murine and human hematopoietic stem and progenitor cells (HSPCs) by the induction of BCL2-regulated apoptosis. Cell death in HSPCs is independent of p53 but requires the BH3-only proteins BIM, PUMA, and NOXA. Moreover, Chk1 is essential for definitive hematopoiesis in the embryo. Noteworthy, cell death inhibition in HSPCs cannot restore blood cell formation as HSPCs lacking CHK1 accumulate DNA damage and stop dividing. Moreover, conditional deletion of Chk1 in hematopoietic cells of adult mice selects for blood cells retaining CHK1, suggesting an essential role in maintaining functional hematopoiesis. Our findings establish a previously unrecognized role for CHK1 in establishing and maintaining hematopoiesis.

References

Aug 29, 1997·The Journal of Biological Chemistry·R N BooherA Fattaey
Dec 28, 1999·Proceedings of the National Academy of Sciences of the United States of America·S OgilvyJ M Adams
Mar 29, 2000·The Journal of Biological Chemistry·E P RogakouW M Bonner
Jan 28, 2003·European Journal of Immunology·Jasper de BoerDimitris Kioussis
Jan 30, 2003·The EMBO Journal·George ZachosDavid A F Gillespie
Jul 21, 2004·Cancer Cell·Michael H LamJeffrey M Rosen
Aug 2, 2005·Proceedings of the National Academy of Sciences of the United States of America·Sandeep GurbuxaniJohn D Crispino
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Kathrin ZauggTak W Mak
Sep 18, 2007·Genesis : the Journal of Genetics and Development·Mandar Deepak MuzumdarLiqun Luo
Jan 9, 2009·Cell Stem Cell·Yan LiuStephen D Nimer
Feb 13, 2009·Nature·Marieke A G EssersAndreas Trumpp
Jan 7, 2010·PloS One·Nathan C BolesJeffrey M Rosen
Feb 11, 2010·Cellular and Molecular Life Sciences : CMLS·Laura CarrassaGiovanna Damia
Feb 26, 2010·Nature Reviews. Immunology·Andreas TrumppAnne Wilson
Nov 23, 2010·Trends in Molecular Medicine·Cynthia X MaHelen Piwnica-Worms
Feb 24, 2011·Development·Alexander MedvinskySamir Taoudi
Apr 25, 2013·International Journal of Cancer. Journal International Du Cancer·Youwei Zhang, Tony Hunter
Jun 12, 2013·Nature Methods·Vanessa RedeckeHans Häcker
Jul 16, 2013·Trends in Cell Biology·Shusil K PanditAlain de Bruin
Dec 21, 2013·Nature Reviews. Molecular Cell Biology·Peter E CzabotarJerry M Adams
Oct 10, 2014·Cell Death & Disease·M J HeroldP Bouillet
Jun 6, 2015·Cell Death and Differentiation·F SchulerA Villunger
Sep 1, 2015·Cell·Rebecca C Burgess, Tom Misteli
Sep 15, 2016·Science Signaling·Laure DavidJean-Sébastien Hoffmann

❮ Previous
Next ❯

Citations

May 14, 2020·Current Opinion in Hematology·Georgina A AndersonKatie L Kathrein
May 28, 2021·Immunology and Cell Biology·Amanda Bello, Berit Jungnickel

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination
flow cytometry
transgenic
PCR
genotyping
FCS
FACS

Software Mentioned

ImageJ
FlowJo®
Prism GraphPad

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.